Agilent buys cell metabolism tech company Seahorse Bio for $235M
Agilent Technologies will expand research on cell metabolism to better understand things like neurodegeneration, aging, cancer, cardiovascular disease and cell physiology with its acquisition of Seahorse Bioscience.